Correlation Between IShares Fundamental and Cipher Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Fundamental and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Fundamental and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Fundamental Hedged and Cipher Pharmaceuticals, you can compare the effects of market volatilities on IShares Fundamental and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Fundamental with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Fundamental and Cipher Pharmaceuticals.

Diversification Opportunities for IShares Fundamental and Cipher Pharmaceuticals

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between IShares and Cipher is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding iShares Fundamental Hedged and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and IShares Fundamental is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Fundamental Hedged are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of IShares Fundamental i.e., IShares Fundamental and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Fundamental and Cipher Pharmaceuticals

Assuming the 90 days trading horizon IShares Fundamental is expected to generate 4.31 times less return on investment than Cipher Pharmaceuticals. But when comparing it to its historical volatility, iShares Fundamental Hedged is 4.23 times less risky than Cipher Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  360.00  in Cipher Pharmaceuticals on December 6, 2024 and sell it today you would earn a total of  779.00  from holding Cipher Pharmaceuticals or generate 216.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

iShares Fundamental Hedged  vs.  Cipher Pharmaceuticals

 Performance 
       Timeline  
iShares Fundamental 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days iShares Fundamental Hedged has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, IShares Fundamental is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Cipher Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

IShares Fundamental and Cipher Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Fundamental and Cipher Pharmaceuticals

The main advantage of trading using opposite IShares Fundamental and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Fundamental position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.
The idea behind iShares Fundamental Hedged and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets